Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Carbamazepine

Carbamazepine
In stock
100mg · 200mg · 400mg
from 20,37 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
24,44 £20,37 £
0,68 £ per tablet

In brief

  • Carbamazepine is prescription-only in the UK and most other jurisdictions (EMA, FDA, MHRA, TGA, Health Canada); it is supplied in pharmacies and by e‑pharmacies only with a valid prescription and is not available OTC.
  • Carbamazepine is used to treat epilepsy (partial and generalised tonic‑clonic seizures), trigeminal neuralgia and as a mood stabiliser in bipolar disorder; it is a carboxamide antiepileptic that stabilises hyperexcited neuronal membranes primarily by blocking voltage‑gated sodium channels and reducing repetitive neuronal firing.
  • Usual doses vary by indication: adults commonly start 100–200 mg twice daily with maintenance typically 800–1,200 mg/day (up to 1,600 mg/day in some cases); trigeminal neuralgia often begins 100 mg twice daily up to 1,200 mg/day; children are dosed by weight (typically 5–20 mg/kg/day divided doses) and elderly require lower starting doses and slower titration.
  • Administration is oral (tablets, prolonged/controlled‑release tablets, chewable tablets, oral suspension); an injectable formulation exists but is uncommon.
  • Onset of action for immediate‑release oral carbamazepine is usually within 1–4 hours; clinical effects for seizure control or neuropathic pain may take days of titration to become apparent.
  • Duration of action depends on formulation: immediate‑release preparations typically act for about 8–12 hours requiring divided dosing, while controlled‑release formulations provide prolonged effects often covering 12–24 hours; note carbamazepine induces its own metabolism over time, altering plasma levels.
  • Avoid alcohol while taking carbamazepine; alcohol increases central nervous system depression (drowsiness, dizziness) and can worsen side effects and seizure control.
  • The most common side effects are dizziness and drowsiness (also nausea, vomiting, mild skin rash, blurred vision, ataxia and hyponatraemia are frequently reported).
  • Would you like to try carbamazepine without a prescription?

Basic Carbamazepine Information

  • INN (International Nonproprietary Name): Carbamazepine; alternate names include Carbamazepinum (Latin) and Carbamazepina (Spanish).
  • Brand Names Available In United Kingdom: Tegretol is the common UK brand; regional generics and prolonged‑release products are supplied under similar packaging.
  • ATC Code: N03AF01 (Nervous System, Antiepileptics, Carboxamide Derivatives).
  • Forms & Dosages: Tablets 100mg, 200mg, 400mg; prolonged/controlled‑release tablets 200mg, 400mg; oral suspension 100mg/5ml; chewable 100mg (regionally); injectable form (Carnexiv) listed for the US.
  • Manufacturers In United Kingdom: International manufacturers supply Tegretol and generics; notable manufacturers include Novartis among others (supply varies by market).
  • Registration Status In United Kingdom: Registered and approved for use; supplied as a prescription‑only medicine (Rx) in the UK.
  • OTC / Rx Classification: Prescription‑only (Rx) in the United Kingdom and other listed regions.

Availability & Prescribing Landscape

The prescription status of carbamazepine means it is supplied only on NHS or private prescriptions across the UK.

GPs initiate repeat prescriptions, specialist neurology clinics manage changes, and hospital teams sometimes hand over treatment to community care.

Regulated online pharmacies and high‑street chains such as Boots, LloydsPharmacy and Superdrug commonly dispense carbamazepine when a valid prescription is supplied.

Pack strengths typically stocked range from 100mg to 400mg, often in blister presentation for adherence and pill identification.

Patients report variable pathways to access: a GP‑issued repeat, a neurology clinic switch of formulation, or hospital discharge prescriptions are common.

Electronic prescribing and pharmacy consultations aid adherence and timely side‑effect reporting.

For UK shoppers searching Tegretol UK or online pharmacy carbamazepine, listings will note NHS prescription carbamazepine status clearly.

  • Typical Access Routes: GP repeat prescription; specialist neurology clinic; hospital discharge to community pharmacy.

Patient Experience Highlights

Many patients describe carbamazepine as effective for focal seizures and for trigeminal neuralgia pain control.

Common drawbacks reported are the interaction burden with other medicines and tolerability issues such as drowsiness.

Hyponatraemia is a recognised risk, especially in older people, and patients note periodic blood tests during treatment.

Regional differences in cost matter: prescriptions are free in Scotland, Wales and Northern Ireland but there is a charge in England unless exempt.

Electronic prescriptions and pharmacy counselling commonly improve adherence and prompt reporting of side effects.

Some patients prefer controlled‑release formulations to reduce dosing frequency and daytime sedation.

Quick Pros/Cons Summary

  • Pros: Proven efficacy for focal seizures and trigeminal neuralgia; well‑established dosing options.
  • Cons: Significant drug interactions; CNS side effects; monitoring burden (bloods, sodium).

INN, Synonyms And Classification

The International Nonproprietary Name (INN) is carbamazepine.

Alternate names recorded include Carbamazepinum (Latin) and Carbamazepina (Spanish).

Carbamazepine is classified in the ATC system as N03AF01 — a carboxamide derivative within antiepileptics.

This classification places it among first‑line anticonvulsant choices for certain seizure types.

Brands And Local Packaging

Tegretol (Novartis) is the most widely recognised brand in the UK and Ireland, typically supplied in orange‑white cartons with blisters.

Other brand names appearing across Europe and beyond include Finlepsin, Neurotop Retard, Carbatrol and regional generics using local spellings.

Packaging varies by country and may show local language labelling and different blister layouts for 100–400mg strengths.

Brand Name Common Pack Sizes Region
Tegretol 100mg, 200mg, 400mg (blisters) UK, Ireland, Canada, Australia
Finlepsin 200mg (blisters) Scandinavia, Netherlands
Neurotop Retard 200mg, 400mg (CR) Austria, Germany
Carbatrol / Equetro Extended‑release presentations North America

For retail and product pages, show blister front images and box spine to help patients recognise Tegretol packaging easily.

Licensed Indications

Carbamazepine is licensed for focal (partial) seizures and for generalised tonic–clonic seizures.

It is also a first‑line option for trigeminal neuralgia where it delivers reliable pain control in most patients.

Psychiatric use as a mood stabiliser is commonly off‑label and should be managed by specialists.

Off‑Label And Specialist Use

Off‑label uses include bipolar disorder mood stabilisation and certain neuropathic pain syndromes.

UK prescribers balance the benefits with risks such as CYP interactions and teratogenicity when considering off‑label use.

Maintenance for epilepsy is commonly long‑term with periodic review, whereas neuralgia courses may be for several months and tapered where symptoms remit.

Indication Typical Maintenance Dose Band
Epilepsy (Adults) 800–1,200mg/day
Trigeminal Neuralgia Up to 1,200mg/day (titrated)
Bipolar Disorder (Off‑Label) Variable — specialist guidance

Available Forms & Common Strengths

Carbamazepine is available as immediate‑release tablets (100mg, 200mg, 400mg) and as prolonged/controlled‑release tablets (200mg, 400mg).

Oral suspension at 100mg/5ml and chewable 100mg tablets are regionally available.

An injectable formulation (Carnexiv) is recorded for US markets but is not commonly used in UK retail.

Dosage Form Strengths Typical Pack Sizes
Tablets 100mg, 200mg, 400mg 28, 56, 100 (blisters)
Controlled‑Release Tablets 200mg, 400mg 28, 56 (blisters)
Oral Suspension 100mg/5ml 100ml bottle (with dosing syringe)

Product pages should display formulation type, strengths, pack sizes and include patient information leaflets and dosing devices for liquids.

Adult Dosing & Titration

Typical adult initiation is 100–200mg twice daily with gradual titration to response.

Maintenance dosing for epilepsy commonly falls between 800–1,200mg per day depending on response and tolerability.

For trigeminal neuralgia, clinicians often start at 100mg twice daily and titrate to effect.

CR formulations usually permit twice‑daily dosing while immediate‑release forms may require three times daily administration.

  • Example titration: 100mg twice daily for 3–7 days → increase by 100–200mg total per week to target.

Children, Elderly & Hepatic/Renal Adjustments

Children often start at around 10–20mg/kg/day divided, with stepwise titration guided by age and weight.

The elderly need lower starting doses and slower titration due to CNS sensitivity and a higher risk of hyponatraemia.

Liver impairment should prompt avoidance where possible or use of the minimum effective dose with close monitoring.

Renal impairment requires caution and monitoring of carbamazepine and its metabolites rather than a fixed dosing rule.

Absolute Contraindications

Do not use carbamazepine in patients with prior hypersensitivity to carbamazepine or tricyclic compounds.

Atrioventricular block and a history of bone marrow depression are absolute contraindications.

Concurrent or recent use of monoamine oxidase inhibitors (within 14 days) is also contraindicated.

HLA‑B*1502 carriage is an important genetic risk factor in certain ethnic groups and should be considered when relevant.

Warnings, Pregnancy And Regulatory Points

Pregnancy carries teratogenic risk and continuation should be assessed by specialists with documented counselling.

Folic acid supplementation is recommended when carbamazepine is continued in women of childbearing potential.

MHRA guidance requires careful risk–benefit consideration and appropriate documentation when prescribing to women who could become pregnant.

Remember that carbamazepine remains Rx‑only under UK regulation and prescriptions must meet standard labelling and dispensing standards.

Common And Predictable Adverse Effects

Mild to moderate adverse effects include dizziness, drowsiness, nausea and vomiting.

Patients commonly report headache, blurred vision and ataxia during early titration phases.

Mild skin rashes may occur and can precede severe cutaneous reactions; any evolving rash warrants prompt review.

Hyponatraemia (SIADH) and transient leukopenia are recognised and should be on the monitoring checklist.

Serious Risks And Monitoring Schedule

Serious but rare events include agranulocytosis, aplastic anaemia and Stevens‑Johnson syndrome / toxic epidermal necrolysis.

Recommended baseline tests: full blood count, liver function tests and serum sodium prior to or shortly after initiation.

Periodic monitoring of FBC, LFTs and sodium is advised during maintenance; therapeutic drug monitoring supports dose changes.

Adverse Effect Frequency Monitoring Action
Common (dizziness, drowsiness) Clinical review; dose adjustment if persistent
Hyponatraemia Serum sodium baseline and periodic checks
Blood Dyscrasia (rare) Baseline and periodic full blood counts; urgent review for fever or sore throat

Red Flags: fever, sore throat, unexplained bruising, mouth ulcers, widespread rash, severe drowsiness or breathlessness — seek urgent review.

Mechanism & Interaction Risk

Carbamazepine is a potent inducer of hepatic enzymes including CYP3A4 and affects multiple drug pathways.

Induction reduces concentrations of many co‑medicines such as some oral contraceptives, anticoagulants and statins, altering clinical effects.

Enzyme induction also affects other antiepileptics and certain antipsychotics, so interaction checking is essential at prescribing and dispensing.

Practical Management Of Interactions

Flag interacting medicines at point of sale and during pharmacy consultations to ensure safe use.

Women on hormonal contraception should be counselled about reduced efficacy and offered alternative or additional contraception.

Coordinate dose changes with prescribers and consider therapeutic drug monitoring when starting or stopping interacting drugs.

Drug Class Effect Practical Advice
Hormonal Contraceptives Reduced efficacy Advise additional/alternative contraception
Anticoagulants Variable effect on levels Coordinate INR monitoring and prescriber liaison
Other Antiepileptics Altered plasma concentrations Use TDM and clinical monitoring

Indications To Measure Levels

Measure plasma carbamazepine when initiating or titrating, if seizures persist, when toxicity is suspected or when interacting drugs are added or removed.

Testing is also indicated during pregnancy and in significant hepatic or renal impairment, or when adherence is uncertain.

Interpretation & Target Ranges

Typical therapeutic ranges are approximately 4–12 mg/L, but local laboratory reference ranges should be used for interpretation.

Trough (pre‑dose) samples give the most consistent interpretation and can be repeated after dose changes.

When To Test Sample Timing Action
Initiation/Titration Trough sample Adjust dose per level and clinical response
Suspected Toxicity As soon as possible Assess levels, treat symptoms, consider holding dose
Drug Interaction Change Trough after steady state Recheck and liaise with prescriber

Pharmacy pages should note typical turnaround expectations and advise patients that clinicians interpret levels alongside symptoms.

Pregnancy, Breastfeeding And Contraception

Pregnancy requires specialist assessment because of teratogenic risk; decisions balance seizure control against foetal risk.

Folic acid supplementation is advised where carbamazepine is continued in women of childbearing potential.

Breastfeeding may be permitted with monitoring and specialist input; counsel mothers in line with clinical advice.

Overdose, Perioperative And Emergency Measures

Overdose is a medical emergency and can cause CNS depression, cardiac arrhythmias and respiratory compromise.

Perioperative teams should be informed as enzyme induction can alter anaesthetic and adjunct drug levels.

Product pages and pharmacy leaflets should include emergency advice and local urgent care contact details for patients.

Emergency Symptoms: severe drowsiness, irregular heartbeat, breathing difficulty — call emergency services immediately.

Efficacy And Tolerability Comparison

Carbamazepine is a proven option for focal seizures and remains a first‑line choice in classic trigeminal neuralgia.

Oxcarbazepine is often considered as an alternative with a different hyponatraemia profile, though cross‑reactivity for allergic reactions may occur.

Lamotrigine has a favourable cognitive and mood profile and is preferred in some bipolar presentations and where interaction burden must be minimised.

When Carbamazepine Is Preferred

Carbamazepine is preferred when there is established efficacy for a patient’s seizure type or clear benefit in trigeminal neuralgia.

Choose alternatives where teratogenicity, interaction burden or blood dyscrasia risks outweigh expected benefits.

Drug Pros Cons
Carbamazepine Proven efficacy for focal seizures, trigeminal neuralgia Enzyme induction, teratogenic risk, blood monitoring
Oxcarbazepine Fewer enzyme interactions (some benefits) Hyponatraemia still possible; cross‑reactivity risk
Lamotrigine Favourable cognitive profile, useful in bipolar Risk of rash; slower titration

NHS Vs Private Prescribing And Costs

Carbamazepine is prescription‑only and supplied on NHS prescriptions or private prescriptions in the UK.

Prescription charges apply in England unless the patient is exempt; prescriptions are free in Scotland, Wales and Northern Ireland.

Pack price varies by brand and generic status, and online retailers may show different pricing for Tegretol versus generics.

In our online pharmacy, carbamazepine is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Online Pharmacy Best Practice

Buy only from MHRA‑registered and GPhC‑regulated online pharmacies that require a valid prescription upload or EPS linkage.

Product pages must display batch number, expiry date, storage instructions and a professional contact for queries.

Prescribing Route Pros Cons
NHS Prescription Cost coverage for eligible patients Waiting times for renewals
Private Prescription Faster access in some cases Out‑of‑pocket cost
Online Pharmacy Convenience; home delivery Ensure registration and prescription verification

Recommended Storage & Handling

Store carbamazepine between 15–30°C, protected from moisture and direct light.

Do not freeze oral suspensions and keep medicines in their original packaging with the leaflet.

During transport avoid excessive heat; controlled ambient conditions are advised for pharmacy logistics.

Dispensing Advice And Shelf Life

Record batch and expiry on dispensing records and ensure clear labelling for the patient.

Advise patients that suspensions may have an expiry after opening and supply a dosing syringe with liquids.

For controlled‑release tablets remind patients not to crush or chew them.

  • Dispensing Checklist: confirm allergies, pregnancy status, concomitant medicines, supply PIL and monitoring plan.

Counselling Essentials

Explain missed‑dose advice: take the missed dose as soon as remembered unless it is near the next dose; never double up doses.

Counsel about driving and operating machinery until the patient is stable on dose because of drowsiness and dizziness risks.

Warn patients that alcohol can worsen CNS side effects and should be avoided while stabilising.

Discuss contraception and reduced efficacy of hormonal methods due to enzyme induction and offer practical alternatives.

Quick FAQs For Product Pages

  • Can I stop suddenly? No — treatment must be tapered under clinician guidance to avoid seizure worsening.
  • What side effects need urgent review? Fever, rash, mouth ulcers, severe drowsiness or breathlessness require immediate assessment.
  • Is monitoring needed? Yes — baseline and periodic blood tests including FBC, LFTs and serum sodium are recommended.

Offer a downloadable one‑page patient handout at the pharmacy counter summarising counselling points and red flags.

Delivery Across United Kingdom

City Region Delivery Time
London England 5-7 days
Birmingham England 5-7 days
Manchester England 5-7 days
Glasgow Scotland 5-7 days
Edinburgh Scotland 5-7 days
Leeds England 5-7 days
Liverpool England 5-7 days
Bristol England 5-9 days
Newcastle Upon Tyne England 5-9 days
Sheffield England 5-9 days
Cardiff Wales 5-7 days
Belfast Northern Ireland 5-9 days

Related products